Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the US.
2021
Antibody-mediated rejection (AMR) is one of the leading causes of graft loss in kidney transplant recipients but little is known about the associated cost and healthcare burden of AMR.We developed ...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
11
References
0
Citations
NaN
KQI